Milestone Pharmaceuticals Inc. Share Price
Stocks
MIST
CA59935V1076
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.7574 USD | +9.58% |
|
+5.41% | -62.50% |
| Market Cap | 97.4M 87.33M 80.62M 73.1M 136M 9.27B 138M 965M 384M 4.85B 365M 358M 15.37B | P/E 2026 * |
-0.9x | P/E 2027 * | -0.94x |
|---|---|---|---|---|---|
| Enterprise Value | 97.4M 87.33M 80.62M 73.1M 136M 9.27B 138M 965M 384M 4.85B 365M 358M 15.37B | EV / Sales 2026 * |
27.9x | EV / Sales 2027 * | 4.97x |
| Free-Float |
99.3% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MIST | Delayed | |
CBOE
| MIST | Real-time |
Last Transcript: Milestone Pharmaceuticals Inc.
| 1 day | +9.58% | ||
| 1 week | +5.41% | ||
| Current month | -12.51% | ||
| 1 month | -3.93% | ||
| 3 months | -32.97% | ||
| 6 months | -59.28% | ||
| Current year | -62.50% |
| 1 week | 0.63 |  | 0.77 |
| 1 month | 0.63 | | 0.9 |
| Current year | 0.63 | | 2.34 |
| 1 year | 0.63 | | 3.06 |
| 3 years | 0.63 | | 3.52 |
| 5 years | 0.63 | | 9.85 |
| 10 years | 0 | | 27.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Oliveto
CEO | Chief Executive Officer | 59 | 06/03/2017 |
Amit Hasija
DFI | Director of Finance/CFO | 53 | 08/09/2019 |
David Sandoval
CMP | Compliance Officer | 48 | 09/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Oliveto
BRD | Director/Board Member | 59 | 30/06/2017 |
Michael Tomsicek
BRD | Director/Board Member | 60 | 31/03/2019 |
Lisa Giles
BRD | Director/Board Member | 67 | 30/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/06/26 | Free | Director | 77,000 | 0.0618% | ||
| 20/04/26 | Buy | Chief Executive Officer | 16,584 | 0.0141% | ||
| 20/04/26 | Buy | Chief Executive Officer | 11,556 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.58% | +5.41% | -60.35% | -66.78% | 97.4M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +2.10% | +12.10% | +81.21% | 54.55B | |
| -0.94% | +0.77% | +8.85% | +100.19% | 53.59B | |
| +2.76% | +4.18% | +28.34% | +55.07% | 44.75B | |
| +2.00% | -2.90% | +18.37% | +119.04% | 41.62B | |
| +1.34% | -3.98% | +225.44% | +914.08% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +48.65% | +106.84% | +92.73% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +5.06% | -0.76% | +40.91% | +139.86% | 38.05B | |
| Weighted average by Cap. | +3.24% | -0.29% | +47.53% | +161.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.49M 3.13M 2.88M 2.62M 4.88M 332M 4.94M 34.52M 13.75M 174M 13.07M 12.8M 550M | 19.61M 17.58M 16.23M 14.72M 27.44M 1.87B 27.82M 194M 77.39M 977M 73.56M 72.02M 3.09B |
| Net income | -117M -105M -96.49M -87.5M -163M -11.1B -165M -1.15B -460M -5.81B -437M -428M -18.39B | -126M -113M -105M -94.83M -177M -12.03B -179M -1.25B -499M -6.3B -474M -464M -19.93B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | US$0.7574 | +9.58% | 831,451 |
| 27/10/26 | US$0.6912 | +7.26% | 754,472 |
| 26/10/26 | US$0.6444 | -0.59% | 802,492 |
| 23/10/26 | US$0.6482 | -7.76% | 1,576,364 |
| 22/10/26 | US$0.7027 | +1.06% | 621,338 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MIST Stock
Select your edition
All financial news and data tailored to specific country editions
